Leen Vanheer

🧬 Take advantage of #omics techniques in this @lshtm.bsky.social course and learn how to analyse genetic epidemiology of diseases like TB, MRSA and @lshtm-malaria.bsky.social

Runs from 20-23 June 2026 #PublicHealth #HealthData

Apply by 20 March 🔽
www.lshtm.ac.uk/study/course...

Behind every breakthrough is a dedicated face in the lab

Meet the scientists & technicians @lshtm.bsky.social & @mrcunitgambia.bsky.social working to understand 🦟 & fight malaria, dengue, Zika, & more.

This #WorldMosquitoDay2025, let’s shine a light on their vital work.

👉 bit.ly/45qtn6F

Ahead of #WorldMosquitoDay2025, we celebrate the brilliant scientists and technicians 👩🏽‍🔬🔬 at @mrcunitgambia.bsky.social and @lshtm.bsky.social whose dedication helps us better understand mosquitoes 🦟

The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data Leen Vanheer and colleagues retrospectively analyzed individual participant data from six clinical trials of antimalarials to identify drug regimens that most effectively kill Plasmodium falciparum ga...

📢 Our paper is now out! Antimalarials stop symptoms, but do they also block onward transmission? We conducted a pooled analysis of 6 clinical trials in Mali with transmission endpoints 🦟

Thankful for great collaborators!

journals.plos.org/plosmedicine...

Two weeks ago today, we held our annual retreat, a vibrant day of discussion, innovation & networking with researchers, students, technicians & admin joining in person and online from @mrcunitgambia.bsky.social, Côte d’Ivoire & beyond. 🌍🦟

🔗 Read more 👉 bit.ly/458cqMJ

Fighting malaria as a patient and scientist - Nature Microbiology Fitsum Tadesse was infected with malaria as a young child in Ethiopia and faced challenges to access efficacious treatment during a time of widespread drug resistance. Today, as a scientist in Africa,...

From surviving malaria as a child to leading cutting-edge research on drug resistance in Africa. Dr Fitsum Tadesse @lshtm.bsky.social is fighting the parasite from both sides. A powerful story of science, and resilience 🧬🌍

Read his journey @NatureMicrobiol 📄
👉 bit.ly/4nWsb22

Expert Comment: First malaria medicine for babies approved | LSHTM The first malaria treatment specifically developed for newborn babies and young infants has been approved for use. The approval, by Switzerland’s medical agency Swissmedic, of Coartem Baby

Professor Umberto D’Alessandro, #MRCG Unit Director shares insights on the first malaria medicine approved for babies.

“Babies have been systematically excluded from clinical trials assessing the safety and efficacy of antimalarial treatments….”

Read more: tinyurl.com/mwftby5h

#EndMalaria

Insights from the 2025 Gordon Research Conference | LSHTM Insights from the 2025 Gordon Research Conference | LSHTM

🦠 “An honour to present” — @leen-vanheer.bsky.social shares insights from the 2025 Gordon Research Conference on Malaria.

From rising resistance in Ethiopia to promising progress in SE Asia, her talk spotlighted urgent AMR trends in Plasmodium falciparum.

Read more 👉 bit.ly/4ef5C4o